Search Results (1 to 10 of 387 Results)
Download search results: CSV END BibTex RIS
Skip search results from other journals and go to results- 90 Journal of Medical Internet Research
- 78 JMIR mHealth and uHealth
- 77 JMIR Research Protocols
- 54 JMIR Formative Research
- 19 JMIR Public Health and Surveillance
- 10 JMIR Pediatrics and Parenting
- 9 JMIR Diabetes
- 8 Interactive Journal of Medical Research
- 7 JMIR Medical Informatics
- 7 JMIR Serious Games
- 5 JMIR Human Factors
- 5 JMIRx Med
- 4 Iproceedings
- 4 JMIR Dermatology
- 2 JMIR Cancer
- 2 JMIR Mental Health
- 1 JMIR AI
- 1 JMIR Aging
- 1 JMIR Cardio
- 1 JMIR Infodemiology
- 1 JMIR Medical Education
- 1 JMIR Rehabilitation and Assistive Technologies
- 0 Medicine 2.0
- 0 iProceedings
- 0 JMIR Preprints
- 0 JMIR Bioinformatics and Biotechnology
- 0 JMIR Challenges
- 0 JMIR Biomedical Engineering
- 0 JMIR Data
- 0 Journal of Participatory Medicine
- 0 JMIR Perioperative Medicine
- 0 JMIR Nursing
- 0 JMIRx Bio
- 0 Transfer Hub (manuscript eXchange)
- 0 JMIR Neurotechnology
- 0 Asian/Pacific Island Nursing Journal
- 0 Online Journal of Public Health Informatics
- 0 JMIR XR and Spatial Computing (JMXR)
In the United Kingdom, 25% of men and 26% of women live with obesity [1]. Overweight and obesity are more prevalent in people living in the most deprived areas compared to the least deprived areas (72% and 58%, respectively) [1]. Similarly, excess weight disproportionately affects people in the Black ethnic group (72% compared to 64% in people from the White ethnic group) [1].
J Med Internet Res 2025;27:e62661
Download Citation: END BibTex RIS
Obesity has reached pandemic proportions and is a major risk factor for type 2 diabetes (T2 D), cardiovascular disease, and other metabolic disorders. Prevention progression to T2 D in individuals with obesity through effective lifestyle interventions is a public health priority Substantial and sustained weight loss achieved through lifestyle modifications is a key strategy to reduce the risk of T2 D and improve metabolic health [1,2].
JMIR Res Protoc 2025;14:e67570
Download Citation: END BibTex RIS
The Role of Mobile Apps in Obesity Management: Systematic Review and Meta-Analysis
Obesity represents one of the major public health challenges of the 21st century. The World Health Organization [1] defines obesity as an abnormal or excessive accumulation of fat that may impair health. Globally, the prevalence of people with obesity is rising steadily, which is a big problem for health, economy, and society. In the United States, projections show that by 2050, the number of adults who are overweight or obese will increase from 172 million in 2021 to 213 million.
J Med Internet Res 2025;27:e66887
Download Citation: END BibTex RIS
Obesity remains a critical public health challenge nationwide, affecting over 100 million adults across the United States according to recent estimates [1]. In the United States, the prevalence of obesity has continued to rise, with over 40% of adults classified as obese in 2023 [2] and rates expected to exceed 60% in 2050, posing a significant public health threat given its impact on the existing chronic disease epidemic [3].
JMIR Mhealth Uhealth 2025;13:e70228
Download Citation: END BibTex RIS
The epidemic of obesity or overweight has gone beyond being a cosmetic concern to become a disease that poses a substantial threat to the well-being of individuals worldwide. Obesity raises the likelihood of developing a series of diseases, such as diabetes, hypertension, arteriosclerosis, hyperlipidemia, cardiovascular disease, and specific types of cancer [1]. Individuals with obesity also grapple with psychological disorders, including depression, lack of self-confidence, and low self-efficacy [2].
JMIR Serious Games 2025;13:e66998
Download Citation: END BibTex RIS
The high and increasing prevalence of obesity across the world is a major challenge for health care delivery and confers a substantial burden on individuals and the health care sector. The effects of obesity are widely recognized as one of the leading health concerns, affecting all age and socioeconomic groups [1].
JMIR Res Protoc 2025;14:e64735
Download Citation: END BibTex RIS
Telemedicine Booths for Screening Cardiovascular Risk Factors: Prospective Multicenter Study
There are several well-known modifiable risk factors for CVD, including obesity, high blood pressure, and physical inactivity [5]. The most significant of these is hypertension because it accounts for the largest number of CVD deaths [5,6]. In France, this affects around 22% of the population, but over a third are unaware that they have the condition because there are usually no symptoms [4,7].
JMIR Hum Factors 2025;12:e57032
Download Citation: END BibTex RIS
The offspring of mothers with pre-existing metabolic diseases—obesity, diabetes, and hypertension—have an increased risk of significant congenital anomalies and premature birth compared with the offspring of mothers without metabolic disease [1]. These offspring are also twice as likely to develop obesity, diabetes, and hypertension in childhood [2].
JMIR Res Protoc 2025;14:e72542
Download Citation: END BibTex RIS
Over the past 2 decades, obesity (ie, BMI ≥30 kg/m2) prevalence among adults in the United States has risen from 30.5% to 42.4% [1], and has nearly tripled worldwide [2]. Further, the prevalence of severe obesity (BMI ≥40 kg/m2) has doubled from 4.7% to 9.2% [3]. Non-Hispanic Black (NHB) adults are disproportionately impacted, with an age-adjusted obesity prevalence of 49.9%, followed by Hispanic (45.6%), non-Hispanic White (NHW) (41.4%), and non-Hispanic Asian (16.1%) individuals [3].
JMIR Form Res 2025;9:e58916
Download Citation: END BibTex RIS
The burden of liver disease increases yearly in Finland because the Finnish population age average grows, and obesity and overweight are more common problems in the Finnish population [1]. On average, there are 1000 deaths caused by alcoholic liver disease every year [2]. For the early detection of individuals from the general population at high risk for future severe liver disease, the CLiv D (Chronic Liver Disease score) score was developed.
JMIR Med Inform 2025;13:e62978
Download Citation: END BibTex RIS